Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2088 of 6351
-
Could a mouth rinse spot hidden HPV cancers in men?
Diagnosis OngoingThis trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and anogenital cancers. Learning the relationship between HPV and cancer risk in men who test positive for HPV antibodies or circulating HPV DNA may help doctors to develop early methods of scree…
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
Could a daily vitamin during pregnancy boost your Child's brain development?
Disease control OngoingScientific basis: Globally, vitamin B12 deficiency is one of the most common micronutrient deficiencies. The only relevant source of vitamin B12 is animal-source foods and poor gut function may decrease absorption. Vitamin B12 is crucial for normal cell division and differentiati…
Phase 2/3 • Sponsor: Centre For International Health • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Experimental drug combo aims to outsmart resistant lung cancer
Disease control OngoingThis phase I trial studies the side effects and best dose of sapanisertib when given together with osimertinib in treating patients with stage IV EGFR mutation positive non-small cell lung cancer that has progressed after treatment with an EGFR tyrosine kinase inhibitor. Sapanise…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Simple blood test could spot Alzheimer's early
Diagnosis CompletedThe ADCHIP study (ST0067) is a non-interventional, monocentric, prospective study conducted by Amoneta Diagnostics and the Leenaards Memory Center (Lausanne, Switzerland). Its main objective is to develop and validate a microfluidic chip-based protocol that stabilizes human red b…
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Zapping the brain to fight Parkinson's fog
Symptom relief Recruiting nowParkinson's disease (PD) has been classically regarded as a "movement disorder", so earlier work has focused on treating motor symptoms only. As PD patients now have longer life expectancy, the relatively slowly progressing cognitive deficits (compared to their motor deficits) ha…
Sponsor: University of Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New heart valve implant offers hope for congenital heart patients
Disease control CompletedThe purpose of this study is to evaluate the safety and effectiveness of the TPV in patients with pulmonary valve dysfunction.
Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 13:31 UTC
-
New combo tackles tough bladder cancer: timing may matter
Disease control OngoingThe purpose of this study is to compare any good and bad effects the study drug atezolizumab has on the cancer when combined with the standard chemotherapy drugs gemcitabine and cisplatin (or GC) in two different dosing schedules: chemotherapy (GC) before atezolizumab vs. GC afte…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy shows promise for kids with Transplant-Related cancer
Disease control CompletedThis pilot phase II trial studies how well rituximab and latent membrane protein (LMP)-specific T-cells work in treating pediatric solid organ recipients with Epstein-Barr virus-positive, cluster of differentiation (CD)20-positive post-transplant lymphoproliferative disorder. Rit…
Phase 2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New hope for rare cancers: drug targets genetic weakness
Disease control OngoingThis phase II MATCH treatment trial tests how well palbociclib (PD-0332991) works in treating patients with cancer that has certain genetic changes. Palbociclib (PD-0332991) is in a class of medications called kinase inhibitors. It is used in patients whose cancer has a certain m…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can pregnancy and neurological disease coexist safely? a new registry seeks answers
Knowledge-focused Recruiting nowPRISMA, is a pregnancy registry study, focused on comprehensively collecting information about pregnancy in women with chronic neurological conditions from across the United States and internationally. Depending on their specific condition (MS, CIS, NMOSD, or other) and their sp…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can diet and exercise before pregnancy reduce baby fat?
Disease control CompletedStudies evaluating lifestyle intervention in obese women during pregnancy have reported limited success in decreasing excessive gestational weight gain, and have failed to achieve the key outcome of breaking the obesity cycle and reducing neonatal adiposity or birth weight. Altho…
Sponsor: Tufts Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Radiation and immunotherapy combo shows promise in small cancer study
Disease control CompletedThis study is a pilot study to evaluate high-dose conformal radiation therapy (HDCRT) administered in combination with pembrolizumab in patients with solid tumors.
Phase 1 • Sponsor: James Larner, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a pill plus light therapy restore skin color in vitiligo?
Disease control CompletedVitiligo is a depigmentation disorder affecting 0.5 to 2% of the general population. It is an acquired pigmentary disorder of the skin and mucous membranes that is characterized by circumscribed, depigmented macules and patches. Apremilast is a phosphosdiesterase 4 (PDE4) inhibit…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can yearly MRIs catch second cancers in retinoblastoma survivors?
Knowledge-focused OngoingThe purpose of this study is to assess the benefit of MR screening for asymptomatic head \& neck (or CNS) second primary cancers occurring in hereditary retinoblastoma patients previously treated by external beam radiation therapy (EBRT).
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:56 UTC
-
Experimental drug cocktail aims to outsmart childhood cancers
Disease control Recruiting nowInvestigators are testing new experimental drug combinations such as the combination of vorinostat, vincristine, irinotecan, and temozolomide in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy. T…
Phase 1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Targeted drug poziotinib tested in rare lung cancer mutations
Disease control Stopped earlyThis phase II trial studies how well poziotinib works in treating patients with non-small lung cancer with an EGFR or HER2 exon 20 mutation that is stage IV or has come back (recurrent). Poziotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
To cut or not to cut: a trial questions routine appendectomy for normal appendices
Disease control CompletedBased on a regional cohort, this study we will try to demonstrate the superiority of routine laparoscopic appendectomy vs. leaving an intraoperative assessed normal appendix in situ in cases of normal findings at diagnostic laparoscopy. If routine laparoscopic appendectomy is not…
Sponsor: Nordsjaellands Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Two-Drug combo takes aim at deadly thyroid cancer
Disease control OngoingThe purpose of this study is to test the safety and tolerability of this treatment combination of paclitaxel and trametinib. Additionally, this study aims to to find out what effects the combination of paclitaxel and trametinib has on the shrinkage and growth of anaplastic thyroi…
Early phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Glow-in-the-Dark dye could help detect oral cancer
Diagnosis OngoingThe purpose of this study is to test if an investigational dye, called PARPi-FL, can be used to detect this type of cancer. This will be the first time that PARPi-FL is being tried in people. First, the investigators will test the safety of PARPi-FL at different doses to find out…
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Artificial intelligence reads brain scans to detect deadly tumors
Diagnosis CompletedThe goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-MG can help detect a specific molecular type of brain tumour called molecular glioblastoma using routine MRI scans. The study uses previously collected and fully anonymised …
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC